Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]
Authors Pang X, Zhang L, Bai F, Wang N, Garner RE, McKallip R, Zhao Z
Received 9 June 2020
Accepted for publication 9 June 2020
Published 26 June 2020 Volume 2020:14 Pages 2515—2516
Pang X, Zhang L, Bai F, et al. Drug Des Devel Ther. 15;9:6043–6054.
The authors have advised there is an error in theWestern blot bands shown in Figure 6 on page 6050, pSmad2 at 2 weeks.
Each band shown in Figure 6 represents one animal, and six or seven animals were used for each group. The statistical difference was calculated from the protein analysis using every animal tissue sample. Once the overall group statistical difference was found, three bands were chosen to represent the difference more closely between the control (Con) and curcumin (Cur) groups. The authors acknowledge the error in using the same bands in lanes two and three to show pSmad 2 at 2 weeks in the Con group. The data have been newly and independently validated from additional samples, and the results have demonstrated symmetrical expression of pSmad2 in the Con group as shown in the correct Figure 6 below.
The authors apologize for this error.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]